Feasibility, safety, and efficacy of salvage radical prostatectomy after Tookad® Soluble focal treatment for localized prostate cancer

World Journal of Urology

Volumn 33, Issue 7, 2015, Pages 965-971

  Lebdai, Souhil ^a   Villers, Arnaud ^b   Barret, Eric ^c   Nedelcu, Cosmina ^a   Bigot, Pierre ^a   Azzouzi, Abdel Rahmène ^a  

^a ANGERS UNIVERSITY HOSPITAL   (France)

^b LILLE UNIVERSITY HOSPITAL   (France)

^c INSTITUT MUTUALISTE MONTSOURIS   (France)

Author keywords

Focal therapy; Prostate cancer; Radical prostatectomy; Salvage therapy; Vascular targeted photodynamic therapy; WST11 TOOKAD Soluble

Indexed keywords

BACTERIOCHLOROPHYLL; PALLADIUM-BACTERIOPHEOPHORBIDE; PHOTOSENSITIZING AGENT;

AGED; HUMAN; MALE; MIDDLE AGED; PATHOLOGY; PHOTOCHEMOTHERAPY; PROSTATECTOMY; PROSTATIC NEOPLASMS; SALVAGE THERAPY; SURGERY; TREATMENT OUTCOME; TUMOR RECURRENCE;

AGED; BACTERIOCHLOROPHYLLS; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PROSTATECTOMY; PROSTATIC NEOPLASMS; SALVAGE THERAPY; TREATMENT OUTCOME;

EID: 84933178215     PISSN: 07244983     EISSN: 14338726     Source Type: Journal    
DOI: 10.1007/s00345-015-1493-8     Document Type: Article

References (23)

1. Ferlay JS-FE, Lortet-Tieulent J, Rosso S, Coebergh JW, Comber H, Forman D, Bray F (2012) Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer 2013:1374–1403
2. Jemal A, Siegel R, Ward E et al (2008) Cancer statistics. CA Cancer J Clin 58:71–96
3. Sanda MG, Dunn RL, Michalski J et al (2008) Quality of life and satisfaction with outcome among prostate-cancer survivors. N Engl J Med 20(358):1250–1261
4. Choo R, Klotz L, Danjoux C et al (2002) Feasibility study: watchful waiting for localized low to intermediate grade prostate carcinoma with selective delayed intervention based on prostate specific antigen, histological and/or clinical progression. J Urol 167:1664–1669
5. Moore CM, Pendse D, Emberton M (2009) Photodynamic therapy for prostate cancer–a review of current status and future promise. Nat Clin Pract Urol 6:18–30
6. Azzouzi AR, Barret E, Moore CM et al (2013) TOOKAD((R)) Soluble vascular-targeted photodynamic (VTP) therapy: determination of optimal treatment conditions and assessment of effects in patients with localised prostate cancer. BJU Int 112:766–774
7. Eymerit-Morin C, Zidane M, Lebdai S, Triau S, Azzouzi AR, Rousselet MC (2013) Histopathology of prostate tissue after vascular-targeted photodynamic therapy for localized prostate cancer. Virchows Arch 463(4):547–552
8. Moore CM, Azzouzi AR, Barret E et al (2014) Determination of optimal drug dose and light dose index to achieve minimally invasive focal ablation of localized prostate cancer using WST11-Vascular Targeted Photodynamic (VTP) therapy. BJU Int. doi:10.1111/bju.12816
9. Heidenreich A, Bellmunt J, Bolla M, Joniau S et al (2014) EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and treatment of clinically localised disease. Eur Urol 65(1):124–137
10. Thomas C, Jones J, Jager W, Hampel C, Thuroff JW, Gillitzer R (2010) Incidence, clinical symptoms and management of rectourethral fistulas after radical prostatectomy. J Urol 183:608–612
11. Salomon L, Azria D, Bastide C et al (2010) Recommendations Onco-Urology 2010: prostate cancer. Prog Urol 20(Suppl 4):S217–S251
12. Ficarra V, Novara G, Artibani W et al (2009) Retropubic, laparoscopic, and robot-assisted radical prostatectomy: a systematic review and cumulative analysis of comparative studies. Eur Urol 55:1037–1063
13. Leonardo C, Franco G, De Nunzio C et al (2012) Salvage laparoscopic radical prostatectomy following high-intensity focused ultrasound for treatment of prostate cancer. Urology 80:130–133
14. Gotto GT, Yunis LH, Vora K, Eastham JA, Scardino PT, Rabbani F (2010) Impact of prior prostate radiation on complications after radical prostatectomy. J Urol 184:136–142
15. Lawrentschuk N, Finelli A, Van der Kwast TH et al (2011) Salvage radical prostatectomy following primary high intensity focused ultrasound for treatment of prostate cancer. J Urol 185:862–868
16. Stolzenburg JU, Bynens B, Do M, Rabenalt R, Katsakiori PF, Liatsikos E (2007) Salvage laparoscopic extraperitoneal radical prostatectomy after failed high-intensity focused ultrasound and radiotherapy for localized prostate cancer. Urology 70:956–960
17. Chade DC, Eastham J, Graefen M et al (2012) Cancer control and functional outcomes of salvage radical prostatectomy for radiation-recurrent prostate cancer: a systematic review of the literature. Eur Urol 61:961–971
18. Ficarra V, Novara G, Rosen RC et al (2012) Systematic review and meta-analysis of studies reporting urinary continence recovery after robot-assisted radical prostatectomy. Eur Urol 62:405–417
19. Borboroglu PG, Sands JP, Roberts JL, Amling CL (2000) Risk factors for vesicourethral anastomotic stricture after radical prostatectomy. Urology 56:96–100
20. Kostakopoulos A, Argiropoulos V, Protogerou V, Tekerlekis P, Melekos M (2004) Vesicourethral anastomotic strictures after radical retropubic prostatectomy: the experience of a single institution. Urol Int 72:17–20
21. van den Ouden D, Hop WC, Schroder FH (1998) Progression in and survival of patients with locally advanced prostate cancer (T3) treated with radical prostatectomy as monotherapy. J Urol 160:1392–1397
22. Van Poppel H, Vekemans K, Da Pozzo L et al (2006) Radical prostatectomy for locally advanced prostate cancer: results of a feasibility study (EORTC 30001). Eur J Cancer 42:1062–1067
23. Loeb S, Smith ND, Roehl KA, Catalona WJ (2007) Intermediate-term potency, continence, and survival outcomes of radical prostatectomy for clinically high-risk or locally advanced prostate cancer. Urology 69:1170–1175